Latest disclosed round
Series C
- Date
- 2021-02-01
- Amount
- GBP 69.2m
- Sector
- Biotech & techbio
- Companies House
- 10076821
Later stage / growth
Evox Therapeutics
Exosome-based drug delivery
VerifiedSeries COxford
Evidence status
Directory ready
- Identity
- Verified
- Match
- Verified
- Operating status
- active
- Data origins
- Core directory, Live Chris T D1
Capital network
2 linked investors
Funding record
3 disclosed rounds
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2021-02-01 | Series C | £69.2M | Redmile Group |
| 2018-09-01 | Series B | £35.5M | Not stated |
| 2016-01-01 | Series A | £10M | Oxford Sciences Innovation |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.